Navigation Links
Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
Date:5/9/2011

"The data from this study demonstrate that patients treated with fidaxomicin were significantly less likely to suffer a relapse of the initial infection within the first two weeks after completing therapy. The data also suggest that late recurrence is likely due to a reinfection from the environment, particularly in patients with risk factors such as elevated white blood cells and low albumin levels at the end of therapy and exposure to concomitant antibiotics."

The second poster presented today demonstrates that DIFICID is minimally absorbed with plasma levels in the low ng/mL range while maintaining high fecal concentration that are well in excess of the MIC90 versus C. difficile. The analysis measured the concentration of DIFICID and its metabolite, OP-1118, in the plasma and feces of patients treated with the drug in the Phase 3 clinical studies. Plasma concentrations were in the low nanogram per milliliter (ng/mL) range for both DIFICID and its metabolite at day 1 and at End-of-Therapy.  By contrast with the plasma concentrations, fecal concentrations were more than 10,000 times higher as fecal levels exceeded 1,000 micrograms/gram (ug/g) for DIFICID and 800 ug/g for its metabolite.  The DIFICID fecal levels were more than 1,000 times the minimum inhibitory concentration for C. difficile of 0.25 ug/mL and consistent with a high level of activity toward the target organism at the intended site of action in the colon.  The poster presentation is titled "High Fecal and Low Plasma Levels of Fidaxomicin and Metabolite OP-1118 in Patients with C. difficile infection:  Combined Results of Two Phase 3 Trials."

"Following oral administration, DIFICID has minimal systemic exposure, even in patients with CDI," said Pam Sears, Ph.D., Executive Director of Biology and Pre-Clinical Science at Optimer.  "These data show that DIFICID tends to stay in the site of infection for this disease."

About DIFICID™
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session
2. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
3. New Study Results Presented on Dexlansoprazole and Lansoprazole Effects on Plavix® (clopidogrel bisulfate)
4. Three Studies Presented at the 2011 SHEA Annual Scientific Meeting Show That the ICU Medical MicroCLAVE® Contributes to a Significant Decrease in Bacterial Transfer and Reduction in Bloodstream Infections
5. REMEDIAL II Results on PLC Systems RenalGuard® to be Presented at ACC 2011s Late Breaking Clinical Trial Session
6. Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting
7. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
8. Advancements in GYN Oncology; Instrumentation and Techniques to be Presented by Nicholas C. Lambrou, M.D. of Miami
9. Urocidin™ Phase III Clinical Trial Results to be Presented at EAU and AUA Conferences
10. New England Patriots Offensive Line Wins Second Annual Madden Most Valuable Protectors Award Presented by Prilosec OTC®
11. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... -- With the introduction of Elekta,s new Leksell Gamma Knife® ... available for more patients with a wider variety of ... system for the brain, integrates advanced motion management, dose ... Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon ... Barcelona . "This is ...
(Date:4/24/2015)... Hampshire , und BARCELONA ... -- (Stand Nr. 4410) iCAD, Inc. (Nasdaq: ... von moderner Bildanalyse, Lösungen für Behandlungsabläufe und ... Krebserkrankungen, hat heute die sofortige Verfügbarkeit des ... Electronic Brachytherapy (eBx ® ) System ® ...
(Date:4/24/2015)... DRAPER, Utah , April 24, 2015 Today, ... of jetpacks, hoverboards, the singularity, and fat-free cronuts: 1-800 CONTACTS ... of contact lenses in just two taps. Two ... the future . The app also features LensGauge ... been in and when you need to reorder. ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2
... Heska Corporation (Nasdaq: HSKA, "Heska" or the "Company"), announced ... organization, Pets Forever, has been awarded $25,000 as the ... contest. (Logo: http://photos.prnewswire.com/prnh/20000622/HESKALOGO) ... ownership of their pets for as long as possible, ...
... LAKE ZURICH, Ill., Dec. 16, 2010 Fenwal, Inc., ... collection, separation, safety and availability, announced today the U.S. ... to market its ALYX™ component collection system with new ... is a mobile blood component collection device used primarily ...
Cached Medicine Technology:Heska Corporation Awards $25,000 Grand Prize to Pets Forever 2Fenwal Receives FDA Clearance for Wireless Data Export on ALYX Blood-Collection System 2
(Date:4/25/2015)... 2015 By definition, a CIO’s responsibility is ... enterprise relying on their judgement and expertise to keep digital ... to an article published in National Mortgage News on ... doing a disservice to their responsibilities by focusing too heavily ... are crossed when it comes to company policy and industry ...
(Date:4/25/2015)... The impact of the Trivedi Master Wellness™ ... the public and is likely to cause further, more ... June. From March 21st to March 31st, 2015, ... Prayers." More than 600 people participated in the program, ... have reported intense experiences that they attest have transformed ...
(Date:4/25/2015)... Islands, BWI (PRWEB) April 25, 2015 ... has celebrated three months of successfully welcoming visitors to ... 5, 2015. , As part of a major ... Providenciales airport was completely redesigned to speed up arrivals. ... the process of getting out of the airport and ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... April 25, 2015 Parker and Sons projects ... cooling, has spiked in Arizona alongside the growing economy. As ... forty employees for April to help account for the rising ... employees in April is something we are enthusiastic about. It ... Paul Kelly, president at Parker and Sons. , Indeed, Parker ...
Breaking Medicine News(10 mins):Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 2Health News:Trivedi Master Wellness™ Announces the Resounding Success of their Special Prayers Human Wellness Program 3Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Parker and Sons Plans to Expand in 2015 2
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) ... and caloric overindulgence can be easily worked off at the ... just a month,s worth of unhealthy living changes physiology, making ... of [over-eating] can have later long-term effects," said study co-author ...
... researchers at Mayo Clinic discovered several years ago that laboratory ... using to help them find new treatments for this lethal ... quickly became evident that the situation in their lab was ... lines that were supposed to originate from patients with this ...
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... by a U.S. judge to halt any expansion ... temporary injunction, which basically blindsided the scientific community, effectively ... days. That was when then-President Bush ordered that federal ...
... homosexuality and alternate genders isn,t strictly limited to the ... American and native Alaskan groups -- or native nations. ... Kansas State University researcher. Lisa Tatonetti, associate professor ... to "Native Cultures of Western Alaska and the Pacific ...
... ovulating women buy sexier clothing, according to a new study ... unlike the chimps featured on the Discovery Channel, women become ... each month when they are ovulating. The desire for women ... is driven by a desire to outdo attractive rival women," ...
... HealthDay Reporter , MONDAY, Aug. 23 (HealthDay News) -- ... may play a role in chronic fatigue syndrome, a ... , , Using blood samples collected in the mid-1990s ... researchers found evidence of gene sequences for murine leukemia ...
Cached Medicine News:Health News:Short-Term Overeating Could Make Long-Term Weight Loss Tougher 2Health News:Mayo researchers develop new laboratory cell lines to study treatment for ATC 2Health News:Mayo researchers develop new laboratory cell lines to study treatment for ATC 3Health News:Scientists Dismayed by Stem Cell Research Ruling 2Health News:Scientists Dismayed by Stem Cell Research Ruling 3Health News:K-State professor's book is first to explore Two-Spirit literature in Northwest native groups 2Health News:K-State professor's book is first to explore Two-Spirit literature in Northwest native groups 3Health News:Mama wears Prada: Ovulating women buy sexier clothing 2Health News:More Evidence Virus Plays Role in Chronic Fatigue Syndrome 2Health News:More Evidence Virus Plays Role in Chronic Fatigue Syndrome 3
Data Trol™ Normal Control Serum provides the laboratory with vital information on the performance of clinical chemistry assays in the Normal range....
... Data Trol™ Abnormal Control Serum is intended for ... clinical chemistry assays. It is for in vitro ... 5ml lyophilized format, the control offers up to ... reconstituted. The control is to be used in ...
... WEBeBiller® is used for the ... for independent medical billers. It ... will generate and transmit claims ... / commercial insurance carriers. It ...
PowerMed is a billing software....
Medicine Products: